Bromocriptine and psychosis: A literature review
- Alan Boyd D.O.
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.
Wood DF, Johnston JM, Johnston DG: Dopamine, the dopamine receptor and putuitary tumors. Clinical Endocrinology 35:455–466, 1991.PubMed
Davis KL, Kahn RS, Ko, G, et al: Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 148(11):1474–1486, 1991.PubMed
Parkes D: Bromocriptine. New England Journal of Medicine 301:873–878, 1979.PubMed
Blackwell RE, Bradley EL, Kline LB, et al: Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study. Fertility and Sterility 39(6):744–748, 1983.PubMed
Brook NM, Cookson IB: Bromocriptine-induced mania? (Letter) British Medical Journal 1:790, 1978.
Vlissides DN, Gill D, Castelow J: Bromocriptine-induced mania? (Letter) British Medical Journal 1:510, 1978.
Lipper S: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lancet 2(7985):571–572, 1976.CrossRef
Vogel HP, Schiffter R: Hypersexuality — a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatry 16:107–110, 1983.
Montastruc JL, Rascol O, Rascol A: A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry 52:773–775, 1989.
Ostergaard K, Dupont, E: Clozapine treatment of drug-induced psychotic symptoms of late stages of Parkinson's disease. Acta Neurologica Scandinavica 78:349–350, 1988.PubMed
Serby M, Angrist B, Lieberman A: Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. American Journal of Psychiatry 135:1227–1229, 1978.PubMed
Cummings, JL: Behavioral complications of drug treatment of Parkinson's disease. Journal of the American Geriatrics Society 39:708–716, 1991.PubMed
Burton K, Larsen TA, Robinson RG, et al: Parkinson's disease: a comparison of mesulergine and bromocriptine. Neurology 35:1205–1208, 1985.PubMed
Friedman JH, Max J, Swift, R: Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and l-dopa. Clinical Neuropharmacology 10(5):470–475, 1987.PubMed
Iffy L, Lindenthal J, Szodi Z, et al: Puerperal psychosis following ablaction with bromocriptine. Medicine and Law 8(2):171–174, 1989.PubMed
Canterbury RJ, Haskins B, Kahn N, et al: Postpartum psychosis induced by bromocriptine. Southern Medical Journal 80(11):1463–1464, 1987.PubMed
Kemperman CJF, Zwanniken GJ: Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea. Journal of the Royal Society of Medicine 80:387–388, 1987.PubMed
Lake CR, Reid A, Martin C, et al: Cyclothymic disorder and bromocriptine: predisposing factors for postpartum mania? Canadian Journal of Psychiatry 32:693–694, 1987.
Steinbeck K, Turtle JR: Treatment of acromegaly with bromocriptine. Australian and New Zealand Journal of Medicine 9:217–224, 1979.PubMed
LeFeuvre CM, Isaacs AJ, Frank OS: Bromocriptine-induced psychosis in acromegaly. British Medical Journal 285:1315, 1982.
Vance ML, Evans WS, Thorner MO: Bromocriptine. Annals of Internal Medicine 100:78–91, 1984.PubMed
Cabeza GA, Flores LF, Inigues IE, et al: Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma. Revista de Investigacion Clinica 36(2):147–149, 1984.PubMed
Einarson TR, Turchet, EN: Psychotic reaction to low-dose bromocriptine. Clinical Pharmacy 2(May–June):273–274, 1983.PubMed
Turner TH, Cookson JC, Wass JAH, et al: Psychotic reactions during treatment of pituitary tumors with dopamine agonists. British Medical Journal 289:1101–1103, 1984.PubMed
Taneli B, Ozaskinli S, Kirli S, et al: Bromocriptine-induced schizophrenic syndrome. American Journal of Psychiatry 143(7):935, 1986.
Johnson JM: Treated mania exacerbated by bromocriptine. American Journal of Psychiatry 138:980–982, 1981.PubMed
Pearson KC: Mental disorders from low dose bromocriptine (Letter). New England Journal of Medicine 305:173, 1978.
Procter AW, Littlewood R, Fry AH: Bromocriptine-induced psychosis in acromegaly. British Medical Journal 286:50, 1983.PubMed
Frye PE, Pariser SF, Kim MH, et al: Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia. Journal of Clinical Psychiatry 43(6):252–253, 1982.PubMed
Dorevitch A, Aronzon R, Stark M: Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia. Acta Obstetricia et Gynecologica Scandinavica 70:375–376, 1991.PubMed
Einarson TR, Turchet EN: Follow-up on bromocriptine-induced psychosis. Clinical Pharmacy 2(Nov–Dec):512, 1983.
Beaumont PJV, Gelder MG, Friesen HG, et al: The effects of phenothiazines on endocrine function: I Patients with inappropriate lactation and amenorrhea. British Journal of Psychiatry 124:413–419, 1974.PubMed
Beaumont P, Bruwer J, Pimstone B, et al: Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhea. British Journal of Psychiatry 126:285–288, 1975.PubMed
Perovich RM, Lieberman JA, Fleischhacker WW, et al: The behavioral toxicity of bromocriptine in patients with psychiatric illness. Journal of Clinical Psychopharmacology 9(6):417–422, 1989.PubMed
- Bromocriptine and psychosis: A literature review
Volume 66, Issue 1 , pp 87-95
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Human Sciences Press
- Additional Links
- Alan Boyd D.O. (1)
- Author Affiliations
- 1. Tulane Medical Center, Department of Psychiatry and Neurology, Tulane University, 1430 Tulane Avenue, 70112-2699, New Orleans, Lousiana